On Friday, Moderna dosed the first participants in a trial to test whether its coronavirus shot can block infection, but experts have questioned the medical validity of its first trial as well as its financial gains.
- Moderna launches second phase trial for its coronavirus vaccine Daily Mail
- Moderna’s coronavirus vaccine announcement set off a frenzy on Wall Street. Now some are calling for an investigation CNN
- Anthony Fauci on Covid-19 reopenings, vaccines, and ‘warp speed’ STAT
- Fauci says early data for Moderna coronavirus vaccine ‘very promising’ – Business Insider Business Insider
- Moderna Starts a Phase 2 Clinical Trial for Its COVID-19 Vaccine Motley Fool